Fas expression at diagnosis as a biomarker of azacitidine activity in high-risk MDS and secondary AML
2012
Fas expression at diagnosis as a biomarker of azacitidine activity in high-risk MDS and secondary AML
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
15
References
25
Citations
NaN
KQI